Site 2644 University of California, Irvine — Irvine, California

Site 2644 University of California, Irvine is a clinical research site located in Irvine, California, United States 92868.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Site 2644 University of California, Irvine has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Renal Cell Carcinoma.

Sponsors: SillaJen, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site 2644 University of California, Irvine?

Site 2644 University of California, Irvine has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site 2644 University of California, Irvine conducted?

Site 2644 University of California, Irvine has 1 clinical trials on record, with 1 currently active. Their work covers Renal Cell Carcinoma.

Is Site 2644 University of California, Irvine accredited by Crixeo Health?

Site 2644 University of California, Irvine has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site 2644 University of California, Irvine?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.